» Articles » PMID: 39161244

Patients' and Care Providers' Reported Barriers and Suggestions for Improving HIV Viral Load Testing in Tanzania: A Qualitative Study in Dar Es Salaam

Overview
Publisher Sage Publications
Date 2024 Aug 20
PMID 39161244
Authors
Affiliations
Soon will be listed here.
Abstract

The study explores barriers and suggestions for improving viral load testing (VLT) uptake in Tanzania, revealing that only 58% of patients receive VLT annually, contrary to the Tanzanian National Guidelines toward the 95-95-95 UNAIDS targets. Twelve individual interviews and three patient-focus groups were conducted as part of a qualitative study conducted in six human immunodeficiency virus (HIV) clinics in Dar es Salaam to identify potential suggestions for access enhancement, as well as barriers to VLT uptake. Using King's theory of goal attainment, we found that missing appointments was the primary individual barrier to VLT uptake, along with limited knowledge among individuals living with HIV. Participants also face system-level barriers, such as a lack of integrated care and evening service availability. The study suggests that, despite challenges, there is potential for improvement in the uptake and quality of VLT services in Tanzanian public health facilities through a holistic approach.

References
1.
Matanje Mwagomba B, Ameh S, Bongomin P, Juma P, MacKenzie R, Kyobutungi C . Opportunities and challenges for evidence-informed HIV-noncommunicable disease integrated care policies and programs: lessons from Malawi, South Africa, Swaziland and Kenya. AIDS. 2018; 32 Suppl 1:S21-S32. DOI: 10.1097/QAD.0000000000001885. View

2.
Nakalega R, Mukiza N, Kiwanuka G, Makanga-Kakumba R, Menge R, Kataike H . Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda. BMC Infect Dis. 2020; 20(1):727. PMC: 7539500. DOI: 10.1186/s12879-020-05461-1. View

3.
Roberts T, Cohn J, Bonner K, Hargreaves S . Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges. Clin Infect Dis. 2016; 62(8):1043-8. PMC: 4803106. DOI: 10.1093/cid/ciw001. View

4.
Gourlay A, Birdthistle I, Mburu G, Iorpenda K, Wringe A . Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2013; 16:18588. PMC: 3717402. DOI: 10.7448/IAS.16.1.18588. View

5.
Kato I, Tumaini B, Pallangyo K . Prevalence of non-communicable diseases among individuals with HIV infection by antiretroviral therapy status in Dar es Salaam, Tanzania. PLoS One. 2020; 15(7):e0235542. PMC: 7347196. DOI: 10.1371/journal.pone.0235542. View